Scantox

Scantox is the leading Nordic GLP-accredited contract research organization specializing in preclinical pharmacology and regulatory toxicology. It provides comprehensive discovery-to-preclinical services—including in vitro/in vivo efficacy models, formulation development, regulatory toxicology studies and bioanalysis—to pharmaceutical and medical device companies globally. The company has particular expertise in CNS/neurodegenerative disease models and rare disease research. Recent acquisitions have expanded its capabilities to offer an integrated "one-stop-shop" from early lead identification through to clinical trial product manufacturing support.